๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The influence of azone on the transdermal penetration of the dopamine D2 agonist N-0923 in freely moving rats

โœ Scribed by P.J. Swart; F.A.M. Toulouse; R.A. De Zeeuw

Book ID
113365908
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
451 KB
Volume
88
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of the dopamine D2 agon
Pharmacokinetics of the dopamine D2 agonist S(-)-2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in freely moving rats
โœ P. J. Swart; R. A. de Zeeuw ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 503 KB

The pharmacokinetics of the dopamine D2 agonist S( -)-2-(N-propyl-N2-thienylethylamino)-5-hydroxytetralin (1, N-0923) after intravenous, intraperitoneal, and oral administration was studied in freely moving male and female albino Wistar rats. In all cases, the dose was

N-0923, A novel soluble dopamine D2 agon
N-0923, A novel soluble dopamine D2 agonist in the treatment of parkinsonism
โœ Vincent P. Calabrese; K. Alvin Lloyd; Pasquale Brancazio; Eugene Cefali; Pauline ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 614 KB

N-0923, a novel aminotetralin dopamine D2 agonist, was shown to effectively reverse parkinsonian symptoms in nine dopa/agonist-responsive Parkinson's disease patients. The drug was given up to 4.5 hours by continuous intravenous (i.v.) infusion using an i.v. pump. The onset of anti-parkinsonian effe